Correlation Between WUXI BIOLOGICS and Omeros
Can any of the company-specific risk be diversified away by investing in both WUXI BIOLOGICS and Omeros at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining WUXI BIOLOGICS and Omeros into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between WUXI BIOLOGICS UNSPADR2 and Omeros, you can compare the effects of market volatilities on WUXI BIOLOGICS and Omeros and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in WUXI BIOLOGICS with a short position of Omeros. Check out your portfolio center. Please also check ongoing floating volatility patterns of WUXI BIOLOGICS and Omeros.
Diversification Opportunities for WUXI BIOLOGICS and Omeros
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between WUXI and Omeros is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding WUXI BIOLOGICS UNSPADR2 and Omeros in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Omeros and WUXI BIOLOGICS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on WUXI BIOLOGICS UNSPADR2 are associated (or correlated) with Omeros. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Omeros has no effect on the direction of WUXI BIOLOGICS i.e., WUXI BIOLOGICS and Omeros go up and down completely randomly.
Pair Corralation between WUXI BIOLOGICS and Omeros
Assuming the 90 days trading horizon WUXI BIOLOGICS is expected to generate 1.44 times less return on investment than Omeros. But when comparing it to its historical volatility, WUXI BIOLOGICS UNSPADR2 is 4.28 times less risky than Omeros. It trades about 0.26 of its potential returns per unit of risk. Omeros is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 1,027 in Omeros on October 4, 2024 and sell it today you would earn a total of 88.00 from holding Omeros or generate 8.57% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
WUXI BIOLOGICS UNSPADR2 vs. Omeros
Performance |
Timeline |
WUXI BIOLOGICS UNSPADR2 |
Omeros |
WUXI BIOLOGICS and Omeros Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with WUXI BIOLOGICS and Omeros
The main advantage of trading using opposite WUXI BIOLOGICS and Omeros positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if WUXI BIOLOGICS position performs unexpectedly, Omeros can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Omeros will offset losses from the drop in Omeros' long position.WUXI BIOLOGICS vs. UMC Electronics Co | WUXI BIOLOGICS vs. Gladstone Investment | WUXI BIOLOGICS vs. Chuangs China Investments | WUXI BIOLOGICS vs. Methode Electronics |
Omeros vs. Nok Airlines PCL | Omeros vs. Calibre Mining Corp | Omeros vs. JAPAN AIRLINES | Omeros vs. CECO ENVIRONMENTAL |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |